Fcγ receptor engagement
Explore antibody interactions with immune effector cells and tune cell-mediated cytotoxic activity in line with the intended mechanism.
Creative Biolabs helps biopharmaceutical and research teams translate antibody mechanisms into purposeful molecular designs, measurable biological activity, and development-ready workflows.
Creative Biolabs supports teams working to strengthen a desired immune effector function, reduce an unwanted interaction, understand mechanism of action, compare antibody candidates, or prepare an optimized molecule for the next development stage.
Our work is built around the relationships among antibody sequence, Fc structure, glycosylation, receptor or complement binding, cellular response, manufacturability, and product quality. By connecting these variables instead of treating them as isolated tasks, we help clients make better-informed decisions across antibody design, production, functional testing, and development.
Fc-mediated activity is rarely a single-variable problem. The optimal profile depends on the molecule, target biology, intended mechanism, indication, and development strategy. Our teams connect functional intent with molecular design and measurable evidence.
Explore antibody interactions with immune effector cells and tune cell-mediated cytotoxic activity in line with the intended mechanism.
Investigate productive complement engagement and design antibody profiles that support the program's functional objective.
Evaluate phagocytic mechanisms alongside other Fc-dependent functions to build a more complete activity profile.
Examine FcRn interactions when serum persistence and broader pharmacokinetic properties are part of the development strategy.
A coordinated framework connects mechanism-led technology selection, molecular engineering, production, functional testing, characterization, process development, and broader developability work.
Select and combine strategies for ADCC, CDC, dual activity, Fc receptor engagement, complement activation, FcRn-dependent half-life regulation, or Fc silencing.
Explore TechnologiesEngineer Fc sequence and glycosylation to influence FcγR, C1q, and FcRn interactions, including defucosylation, glycoform control, aglycosylation, and combined designs.
View Engineering OptionsTranslate engineering concepts into experimental molecules through stable cell-line construction and coordinated ADCC- or CDC-enhanced antibody production.
Explore Production SupportCompare candidates and investigate mechanism through ADCC, ADCP, CDC, complement-component, complement-function, and cell-based assays.
Explore BioassaysConnect molecular attributes with biological function using receptor and complement binding assays plus glycan profiling and characterization.
View Characterization ServicesAdvance selected molecules through process development and, where appropriate, cGMP ADCC/CDC antibody manufacturing support.
Explore Manufacturing SupportAddress efficacy, safety, pharmacokinetics, stability, solubility, chemical liabilities, heterogeneity, and other developability considerations.
Explore Optimization ServicesCreative Biolabs offers products and research tools that can help laboratories establish assays, access relevant reagents, and evaluate antibody effector functions. The portfolio spans engineered antibody products, cell-based tools, specialized cell lines, glycan-analysis resources, Fc-silent antibodies, and recombinant immunotoxins.
Each work package is aligned to the antibody, target, intended mechanism, development stage, available material, and the decision the study must support.
Clarify the molecule, target, mechanism, reference, development stage, and key technical question.
Align engineering, expression, assay, and analytical choices around defined development questions.
Develop or select candidate molecules, cell lines, assays, and analytical methods for the agreed scope.
Consider functional and analytical data together to distinguish promising changes from meaningful tradeoffs.
Continue into optimization, production, process development, or manufacturing support according to program needs.
Strategies are selected around the intended antibody biology and the decision the client needs to make.
Fc sequence, glycosylation, binding, cellular function, production, and developability can be evaluated as connected variables.
Begin with a sequence, an existing antibody, a reference product, a functional question, an assay challenge, or a development candidate.
Commission a focused service or assemble a workflow extending from design and validation to process and manufacturing support.
Study design, materials, methods, deliverables, and decision points are aligned to each program's scientific and operational needs.
Custom services are complemented by engineered antibody products, cell lines, assay tools, glycan resources, and scientific content.
Whether you are improving ADCC or CDC activity, suppressing Fc-mediated effects, investigating glycosylation, establishing a functional assay, or preparing an optimized antibody for the next development stage, share your molecule, target, development stage, and key technical question with our team.
Creative Biolabs provides luciferase-based ADCC assay. This Jurkat cell based assay is pioneered by Creative Biolabs, and the methodology is very well accepted by the field. See attached ADCC Reporter Assay Protocol for further details.
All products and services are for Research Use Only. Do Not use in humans.
ADCC Assay WT vs AfucoTM Mabs Visit
Antibody Fc Engineering: Towards Better Therapeutics Visit